Foghorn Therapeutics CFO Leaves
source link: https://ceoworld.biz/2024/01/04/foghorn-therapeutics-cfo-leaves/
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
Foghorn Therapeutics CFO Leaves
Foghorn® Therapeutics Inc. (Nasdaq: FHTX) has announced Chief Financial Officer Allan Reine’s departure to pursue a new opportunity. The company has initiated a formal search for a successor, with Dr. Reine’s last day as a full-time Foghorn employee set for January 16, 2024.
Foghorn Therapeutics specializes in identifying and developing medications that target specific genetic dependencies within the chromatin regulatory system.
Adrian Gottschalk, Foghorn’s President and CEO, expressed gratitude for Allan’s leadership and dedication during his tenure.
Have you read?
23 of the Biggest Wars in Human History.
Movies that Catapulted Hollywood Icons.
Countries with the Most American Military Bases.
Countries With The Most Main Battle Tanks Today.
Silver Screen Disasters: Epic Failures in Hollywood.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on:
Google News, LinkedIn, Twitter, and Facebook.
Thank you for supporting our journalism. Subscribe here.
For media queries, please contact: [email protected]
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK